FDC Limited (BOM: 531599)

Market Cap	94.57B
Revenue (ttm)	20.45B
Net Income (ttm)	3.14B
Shares Out	162.81M
EPS (ttm)	19.23
PE Ratio	30.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,174
Open	562.00
Previous Close	563.30
Day's Range	562.00 - 603.80
52-Week Range	344.00 - 603.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmic, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, and analgesics; and anti-oxidants, balanced energy and protein drinks, and vitamins and nutraceuticals, as well as various active pharmaceutical ingredients. It provides its products under the Zifi, Zefu, Zocon, Amodep-AT...

• Industry: Pharmaceutical Preparations
• Founded: 1936
• Employees: 6,659
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531599

Financial Performance

In 2023, FDC Limited's revenue was 19.43 billion, an increase of 8.92% compared to the previous year's 17.84 billion. Earnings were 3.05 billion, an increase of 57.30%.